Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2014 Results
Date:8/7/2014

well as in patients with Smith-Magenis syndrome.

The VLY-686, NK1 antagonist, Phase 2 study in chronic pruritus is ongoing and results are expected in mid-2015.  

2014 FINANCIAL GUIDANCETotal 2014 operating expenses are expected to be between $110.0 and $120.0 million.  This includes intangible asset amortization expense of $2.3 million and $6.0 to $8.0 million of non-cash stock based compensation.

Full HETLIOZ® Prescribing Information can be found at: www.hetlioz.com

CONFERENCE CALLVanda has scheduled a conference call for today, Thursday, August 7, 2014, at 10:00 AM ET.  During the call, Vanda's management will discuss the second quarter 2014 financial results and other corporate activities.  Investors can call 1-800-708-4540 (domestic) and 1-847-619-6397 (international) and use passcode 37729521.  A replay of the call will be available beginning Thursday, August 7, 2014 at 12:30 PM ET and will be accessible until Thursday, August 14, 2014, at 11:59 PM ET.  The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The access number is 37729521.

The conference call will be broadcast simultaneously on Vanda's website, www.vandapharma.com.  Investors should click on the Investor Relations tab and are advised to go to the website at least 15 minutes early to register, download, and install any necessary software or presentations.  The call will also be archived on Vanda's website for a period of 30 days.

ABOUT VANDA PHARMACEUTICALS INC.:Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda, please visit www.vandapharma.com.

CAUTIONARY N
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2013 Results
2. Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013
3. Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock
4. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
5. Vanda Pharmaceuticals Reports Second Quarter 2013 Results
6. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
7. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
8. Vanda Pharmaceuticals, Inc. Sued by Investor
9. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
10. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
11. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014 Zynerba Pharmaceuticals , ... of innovative transdermal synthetic cannabinoid treatments, today announced that ... Annual Healthcare Conference 2014. The conference will be held ... in New York . Zynerba,s Chairman ... 4:50 pm on Tuesday, December 2. To ...
(Date:11/26/2014)... DALLAS , November 25, 2014 ... Surgical Instruments Market by Power Source (Electric, Battery, ... Console, Cables, Blade, Burr, Cart), by Application (Orthopedic, ... 2019" published by MarketsandMarkets, the global Powered Surgical Instruments ... to $1.6 Billion in 2014 and is expected ...
(Date:11/26/2014)... EMERYVILLE, Calif. , Nov. 25, 2014 ... nanotechnology company focused on the development of ... more accurate testing in hospital and pre-hospital ... Standards Organization (ISO) 13485:2003 certification.  The certification ... (BSI), one of the world,s leading certification ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Nanomix Receives ISO 13485:2003 Certification 2
... Tarsa Therapeutics today announced that the Phase III ORACAL ... treatment of postmenopausal osteoporosis was successfully concluded and yielded ... used to support a New Drug Application (NDA) submission ... the fourth quarter of 2011, based on the study ...
... YORK, March 24, 2011 Reportlinker.com announces that ... its catalogue: RNAi Drug ... http://www.reportlinker.com/p0461653/RNAi-Drug-Delivery-Technologies-and-Global-Markets.html THIS ... to how the RNAi (ribonucleic acid interference) technologies market ...
Cached Medicine Technology:Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis 2Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis 3Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis 4Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 2Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 3Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 4Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 5Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 6Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 7Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 8Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 9Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 10Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 11Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 12Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 13Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets 14
(Date:11/27/2014)... 2014 Tylenol lawsuits ( http://www.tylenollawsuitcenter.com/ ) ... by the medication are continuing to move forward in ... ahead to a status conference in December, Bernstein Liebhard ... issued earlier this year, a conference in the Tylenol ... a.m. Items likely to be discussed at the meeting ...
(Date:11/27/2014)... “Wekho” was featured on NewsWatch as part of its monthly ... the iOS, Android, and Windows markets. Andrew Tropeano, a mobile ... review and shared with viewers how it allows users ... way to travel and experience the world has just become ... and it’s a free geolocation app that lets users follow ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Dr. Ronald Receveur, ... has a few oral health tips before patients dig ... offers Louisville and New Albany affordable cosmetic dentistry, ... high in starch and sugar. While the staff wishes everyone ... helpful tips for how patients can enjoy a feast that ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Aria ... Aria Health employees, prepared and donated 200 Thanksgiving ... Lutheran Settlement House , a non-profit, community-based organization ... living in Philadelphia. The dinners were assembled in ... Senior Center, and distributed to vulnerable low income ...
(Date:11/27/2014)... "The uglier, the better," says Dr. Kirk Kimmerling. "Every ... as we enjoy the ugly sweater contest." Last year's ... " It was a sight to see. She glued ... the Christmas balls were faces of the staff with Dr. ... this year, it's simple to get in on the fun. ...
Breaking Medicine News(10 mins):Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 3Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 4Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3
... QGEN ) today announced the Webcast of its third quarter ... EST on,Tuesday, November 11, and will include remarks by Peer M. ... What: Webcast of QIAGEN,s third ... 9:30 a.m. EST on November 11, Where: ...
... Disabilities also documents recent,reductions in disability support as ... 3 From issuing a report,card on each ... community services to recording the annual cost of ... the States in Developmental,Disabilities study by David L. ...
... Release, DENVER, Nov. 3 Global Med ... Board: GLOB), an,international e-Health, medical information technology company, ... results on Thursday, November,13, 2008, before the market ... 9:00 a.m. EST on the same day., ...
... Insulet Corporation,(Nasdaq: PODD ), the global ... Federation (IDF) today announced that Insulet is an,official ... World Diabetes,Day, celebrated on November 14, will raise ... the impact of the disease and,access to care., ...
... pilots prestige beauty model with signature services offered ... WOONSOCKET, R.I., Nov. 3 CVS/pharmacy,announces the ... to change the way women shop for prestige ... for the multi-faceted,time-starved woman. Beauty 360 uses an ...
... belief that older sitters raise likelihood of harm ... as caregivers for children of working parents, the risk of ... study that challenges the widespread belief that children are more ... grandparents. , Compared to organized day care or care ...
Cached Medicine News:Health News:Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Quarter 2008 Financial Results Call Set for November 11 2Health News:New Book Provides 30-Year Analysis of Financial and Programmatic Trends in Services and Funding for People with Intellectual and Developmental Disabilities in the United States 2Health News:Global Med Technologies(R) to Report Third Quarter and Nine-Month Financial Results on Thursday, November 13, 2008 2Health News:Global Med Technologies(R) to Report Third Quarter and Nine-Month Financial Results on Thursday, November 13, 2008 3Health News:Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign 2Health News:Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign 3Health News:CVS/pharmacy Launches Beauty 360 2Health News:CVS/pharmacy Launches Beauty 360 3Health News:Grandparent Caregivers Cut Kids' Injury Risk in Half 2
Standard reading test. "Children should be..."...
Printed with large 20/200 E on one side and a series of five 20/20 tumbling Es on the other- calibrated to a 20 ft. distance. May be used to test and train peripheral awareness....
The PowerLab/4ST is a high-performance recording unit with built-in amplifiers and is suitable for physiology teaching. It has been designed to cover the broad experimental requirements in life scien...
Three Figure Worth Type Test, this test is used for determining diplopia, suppression or fusion in children. Sturdy chrome flashlight comes with red/green glasses. Requires 3 D batteries which are no...
Medicine Products: